UK markets closed

BiomX Inc. (PHGE)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3901-0.0889 (-18.56%)
As of 11:33AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 26.45M
Enterprise value 26.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.59
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.16

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 377.41%
S&P500 52-week change 323.10%
52-week high 30.8550
52-week low 30.1870
50-day moving average 30.3330
200-day moving average 30.3323

Share statistics

Avg vol (3-month) 32.71M
Avg vol (10-day) 3275.77k
Shares outstanding 555.22M
Implied shares outstanding 655.22M
Float 832.39M
% held by insiders 129.80%
% held by institutions 125.72%
Shares short (15 Apr 2024) 4155.07k
Short ratio (15 Apr 2024) 40.45
Short % of float (15 Apr 2024) 40.34%
Short % of shares outstanding (15 Apr 2024) 40.28%
Shares short (prior month 15 Mar 2024) 4442.65k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.90%
Return on equity (ttm)-216.99%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -24.48M
Net income avi to common (ttm)-26.17M
Diluted EPS (ttm)-0.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.91M
Total cash per share (mrq)0.27
Total debt (mrq)15.09M
Total debt/equity (mrq)489.84%
Current ratio (mrq)1.58
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-21.29M
Levered free cash flow (ttm)-12.32M